XML 144 R128.htm IDEA: XBRL DOCUMENT v3.25.0.1
Equity Incentive Plan - Summary of Company's Restricted Stock (Detail)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 90,331
Expected future remaining compensation expense | $ $ 1,052
Expected future compensation expense, restricted shares remaining vesting period 2 years 4 months 2 days
Restricted Shares Awarded on March 14, 2020 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 2,027
Date of Award Mar. 14, 2020
Expected future remaining compensation expense | $ $ 0
Expected future compensation expense, restricted shares remaining vesting period 0 years
Restricted Shares Awarded on March 3, 2021 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 4,944
Date of Award Mar. 03, 2021
Expected future remaining compensation expense | $ $ 47
Expected future compensation expense, restricted shares remaining vesting period 1 year
Restricted Shares Awarded on March 3, 2022 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 6,799
Date of Award Mar. 03, 2022
Expected future remaining compensation expense | $ $ 112
Expected future compensation expense, restricted shares remaining vesting period 2 years
Restricted Shares Awarded on March 3, 2022 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 4,847
Date of Award Mar. 03, 2022
Expected future remaining compensation expense | $ $ 0
Expected future compensation expense, restricted shares remaining vesting period 0 years
Restricted Shares Awarded on March 14, 2023 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 13,062
Date of Award Mar. 14, 2023
Expected future remaining compensation expense | $ $ 218
Expected future compensation expense, restricted shares remaining vesting period 3 years
Restricted Shares Awarded on March 14, 2023 Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 17,431
Date of Award Mar. 14, 2023
Expected future remaining compensation expense | $ $ 188
Expected future compensation expense, restricted shares remaining vesting period 1 year
Restricted Shares Awarded on March 12, 2024 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 26,238
Date of Award Mar. 12, 2024
Expected future remaining compensation expense | $ $ 327
Expected future compensation expense, restricted shares remaining vesting period 4 years
Restricted Shares Awarded on March 12, 2024 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 13,696
Date of Award Mar. 12, 2024
Expected future remaining compensation expense | $ $ 140
Expected future compensation expense, restricted shares remaining vesting period 2 years
Restricted Shares Awarded on August 9, 2024 [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Granted 1,287
Date of Award Aug. 09, 2024
Expected future remaining compensation expense | $ $ 20
Expected future compensation expense, restricted shares remaining vesting period 3 years
Restricted Stock [Member]  
Schedule Of Nonvested Stock Option Activity [Line Items]  
Number of Restricted Shares, Nonvested at beginning of period 85,670
Number of Restricted Shares, Granted 42,239
Number of Restricted Shares, Vested (36,060)
Number of Restricted Shares, Forfeited (1,518)
Number of Restricted Shares, Nonvested at end of period 90,331
Weighted Average Grant Date Fair Value, Nonvested at beginning of period | $ / shares $ 21.88
Weighted Average Grant Date Fair Value, Granted | $ / shares 15.51
Weighted Average Grant Date Fair Value, Vested | $ / shares 21.47
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 21.41
Weighted Average Grant Date Fair Value, Nonvested at end of period | $ / shares $ 19.14